Back to the Top
Could anyone indicate what kind of study is required for an abbreviated
new drug application (ANDA) of topical dermatological drug product
(bioequivalence, skin irritation/sensitization,...), and possibilities
Thanks in advance.
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (email@example.com)